1. Bronaugh, R. L., Goldstein, M. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity. Psychopharmacol. Commun.1, 501–510 (1975).
2. Burt, D. R., Creese, I., Snyder, S. H. Properties of (3H) haloperidol and (3H) dopamine binding associated with dopamine receptors in calf membranes. Mol. Pharmacol.12, 800–812 (1976).
3. Calne, D. B., Teychenne, P. F., Claveria, L. E., Eastman, R., Greenacre, J. K., Petrie, A. Bromocriptine in Parkinsonism. Br. Med. J.4, 442–444 (1974 a).
4. Calne, D. B., Teychenne, P. F., Leigh, P. N., Banji, A. N., Greenacre, J. K. Treatment of Parkinsonism with bromocriptine. Lancet2, 1355 (1974 b).
5. Christensen, J., Squires, R. F. Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro. J. Pharm. Pharmacol.26, 742–743 (1974).